HighTower Advisors »

Zentalis Pharmaceuticals shares owned by HighTower Advisors

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $453k 30k 15.15
2023-09-30 $600k 30k 20.06
2023-06-30 $844k 30k 28.22
2023-03-31 $514k 30k 17.19
2022-12-31 $607k 30k 20.12
2022-09-30 $648k 30k 21.65
2022-06-30 $848k 30k 28.06
2022-03-31 $1.4M 30k 46.16
2021-12-31 $2.5M 30k 84.07
2021-09-30 $2.0M 30k 66.64
2021-06-30 $1.6M 30k 53.20